Clinical Trials
2 trialsNCT01079780 2023-06-28
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00862784 2014-06-17
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
Eli Lilly and Company
Phase 2 Completed